Repligen
RGEN
#2602
Rank
C$9.33 B
Marketcap
C$165.53
Share price
0.01%
Change (1 day)
-4.20%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of December 2025 : C$4.07 Billion

According to Repligen 's latest financial reports the company's total assets are C$4.07 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31C$4.03 B-0.52%
2024-12-31C$4.06 B8.13%
2023-12-31C$3.75 B9.31%
2022-12-31C$3.43 B14.3%
2021-12-31C$3.00 B23.87%
2020-12-31C$2.42 B32.68%
2019-12-31C$1.82 B73.3%
2018-12-31C$1.05 B12.88%
2017-12-31C$0.93 B140.77%
2016-12-31C$0.38 B91.39%
2015-12-31C$0.20 B36.26%
2014-12-31C$0.14 B17.88%
2013-12-31C$0.12 B30.92%
2012-12-31C$96.46 M
2011-03-31C$70.1 M-2.65%
2010-03-31C$72.01 M-22.38%
2009-03-31C$92.77 M32.87%
2008-03-31C$69.82 M107.46%
2007-03-31C$33.65 M0.03%
2006-03-31C$33.64 M0.45%
2005-03-31C$33.49 M-13.48%
2004-03-31C$38.71 M-1.62%
2003-03-31C$39.35 M-15.26%
2002-03-31C$46.44 M-8.46%
2001-03-31C$50.73 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
C$287.66 B 6,956.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$152.48 B 3,640.82%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$179.88 B 4,312.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$124.42 B 2,952.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.12 B-96.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.62 B-60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$6.40 B 57.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$3.48 B-14.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$10.49 B 157.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$9.86 B 141.90%๐Ÿ‡บ๐Ÿ‡ธ USA